Cargando…

PS12. Screening novel compounds for behavioural effects: repurposing epigenetic drugs for psychiatry

Detalles Bibliográficos
Autores principales:	Wang, Dong Yao, Jin, Jian, Choy Wong, Albert Hung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616611/ http://dx.doi.org/10.1093/ijnp/pyw043.012

Ejemplares similares

Repurposing the 7Ps
por: Mulford, A.
Publicado: (2020)

Self-harming behaviour in liaison psychiatry : Case series and literature review
por: BENALLEL, K., et al.
Publicado: (2023)

Epigenetics in Psychiatry
por: Li, Kevin J., et al.
Publicado: (2016)

Prescription of benzodiazepines and related drugs in the Psychiatry Department in the Psychiatry department of Tahar Sfar, Mahdia hospital
por: Brahim, S., et al.
Publicado: (2023)

Virtual screening on the web for drug repurposing: a primer
por: Chen, Yu Wai, et al.
Publicado: (2021)

PS216. Preclinical and clinical assessment of tryptophan catabolites (TRYCATS) as a measure of neuroinflammation and utility in compound screening.
por: Allers, Kelly, et al.
Publicado: (2016)

Drug Repurposing Screening Identifies Novel Compounds That Effectively Inhibit Toxoplasma gondii Growth
por: Dittmar, Ashley J., et al.
Publicado: (2016)

Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2
por: Chen, Catherine Z., et al.
Publicado: (2020)

Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2
por: Chen, Catherine Z., et al.
Publicado: (2021)

Phenotypic screening of low molecular weight compounds is rich ground for repurposed, on-target drugs
por: Lipinski, Christopher A., et al.
Publicado: (2022)

Psychotropic drug repurposing for COVID-19: a systematic review
por: Isayeva, U., et al.
Publicado: (2022)

PS25. Behavioural and structural investigation of fear extinction in the rat
por: CHJ, Park, et al.
Publicado: (2016)

DrugRep: an automatic virtual screening server for drug repurposing
por: Gan, Jian-hong, et al.
Publicado: (2022)

Pathway-Centric Structure-Based Multi-Target Compound Screening for Anti-Virulence Drug Repurposing
por: Xie, Li, et al.
Publicado: (2019)

A Repurposed Drug Screen for Compounds Regulating Aquaporin 5 Stability in Lung Epithelial Cells
por: Villandre, John, et al.
Publicado: (2022)

PS52. Identifying common and distinctive epigenetic alterations between bipolar disorder and schizophrenia
por: Sugawara, Hiroko, et al.
Publicado: (2016)

Screening of GPCR drugs for repurposing in breast cancer
por: Abdulkareem, Noor Mazin, et al.
Publicado: (2022)

Rapid Identification of Antifungal Compounds against Exserohilum rostratum Using High Throughput Drug Repurposing Screens
por: Sun, Wei, et al.
Publicado: (2013)

Drug Repurposing Based on Protozoan Proteome: In Vitro Evaluation of In Silico Screened Compounds against Toxoplasma gondii
por: Cajazeiro, Débora Chaves, et al.
Publicado: (2022)

On psychiatry and psychology
por: Neu, E., et al.
Publicado: (2021)

Psychedelic Psychiatry
por: Nutt, D.
Publicado: (2022)

Drug repurposing screens and synergistic drug‐combinations for infectious diseases
por: Zheng, Wei, et al.
Publicado: (2017)

Insights into bioinformatic approaches for repurposing compounds as anti-viral drugs
por: Zheng, Wenxiao, et al.
Publicado: (2021)

PSYCHIATRY OF CRIMINAL BEHAVIOUR
por: Singh, Gurmeet
Publicado: (1982)

Repurposing an In Vitro Measles Virus Dissemination Assay for Screening of Antiviral Compounds
por: Schmitz, Katharina S., et al.
Publicado: (2022)

1380. Safety of Repurposed Drugs for Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: An Analysis of Adverse Events Reported in the Literature
por: Stone, Heather, et al.
Publicado: (2019)

Repurposing Old Drugs into New Epigenetic Inhibitors: Promising Candidates for Cancer Treatment?
por: Moreira-Silva, Filipa, et al.
Publicado: (2020)

From GWAS to drug screening: repurposing antipsychotics for glioblastoma
por: Lin, Wei-Zhi, et al.
Publicado: (2022)

Correction: Rapid Identification of Antifungal Compounds against Exserohilum rostratum Using High Throughput Drug Repurposing Screens
por: Sun, Wei, et al.
Publicado: (2013)

Correction: Rapid Identification of Antifungal Compounds against Exserohilum rostratum Using High Throughput Drug Repurposing Screens
por: Sun, Wei, et al.
Publicado: (2013)

A Repurposed Drug Screen Identifies Compounds That Inhibit the Binding of the COVID-19 Spike Protein to ACE2
por: Tsegay, Kaleb B., et al.
Publicado: (2021)

Drug repurposing screens identify compounds that inhibit α-synuclein oligomers' membrane disruption and block antibody interactions
por: Somavarapu, Arun Kumar, et al.
Publicado: (2023)

Pad, psychiatry and stigma
por: Kowalinski, E., et al.
Publicado: (2021)

Digital phenotyping in psychiatry
por: Orsolini, L.
Publicado: (2021)

Pad in forensic psychiatry
por: Franke, I.
Publicado: (2021)

Therapeutic isolation in psychiatry
por: Kefi, H. El, et al.
Publicado: (2021)

Suicide postvention in psychiatry
por: Castro, L., et al.
Publicado: (2021)

Neuroimaging in psychiatry: is it relevant?
por: Binic, I., et al.
Publicado: (2022)

Collaborative Use Repurposing Engine (CURE): FDA-NCATS/NIH Effort to Capture the Global Clinical Experience of Drug Repurposing to Facilitate Development of New Treatments for Neglected and Emerging Infectious Diseases
por: Stone, Heather, et al.
Publicado: (2017)

Subject characteristics of medical requests to the Addiction Liaison Psychiatry Unit. 12 years in Hospital del Mar (Barcelona)
por: Fuentes Valenzuela, J. J., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cbij432l0vddgnetp3pvdvp09d